Codes / ICD10CM / T57.0X3A

T57.0X3A Toxic effect of arsenic and its compounds, assault, initial encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic effect of arsenic and its compounds, assault, initial encounter

Summary

This condition describes adverse health effects resulting from exposure to arsenic or its compounds due to assault, with the encounter classified as initial. Arsenic is a toxic metalloid that can cause acute or chronic toxicity, affecting multiple organ systems depending on the dose, route, and duration of exposure. The initial encounter indicates the patient is receiving care for this toxic effect for the first time related to the assault.

Causes

Toxic effects arise from exposure to arsenic or its compounds as a result of assault. This may involve intentional ingestion, inhalation, or dermal contact with arsenic-containing substances administered by another party. Common sources include arsenic compounds found in industrial, agricultural, or household products, such as pesticides, rodenticides, or contaminated materials. The assault context implies deliberate exposure by a third party.

Risk Factors

  • Being a victim of assault involving arsenic exposure.
  • Access to arsenic-containing substances by the perpetrator.
  • Environmental or occupational settings where arsenic is present and accessible to the perpetrator.
  • Lack of protective measures during the assault incident.

Symptoms

  • Gastrointestinal: Nausea, vomiting, abdominal pain, diarrhea.
  • Dermatological: Skin lesions, hyperpigmentation, or desquamation.
  • Neurological: Headache, dizziness, peripheral neuropathy.
  • Systemic: Organ damage (e.g., liver, kidney) depending on exposure severity.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, history of assault, and confirmation of arsenic exposure. Laboratory tests, such as blood, urine, or hair arsenic levels, may be used to quantify exposure. Imaging or organ function tests may assess systemic damage. Documentation of the assault and initial encounter is critical for coding and clinical context.

Treatment Options

Treatment focuses on removing the arsenic source, supportive care, and managing symptoms. This may include decontamination (e.g., gastric lavage, skin washing), chelation therapy (e.g., dimercaprol), and monitoring of organ function. Care is tailored to the route and severity of exposure, with attention to the assault-related context.

Prognosis and Follow-Up

Prognosis depends on the dose, route, and timeliness of treatment. Acute exposure may resolve with prompt care, while chronic or severe exposure can lead to long-term organ damage. Follow-up includes monitoring for delayed effects and addressing any assault-related injuries or psychological impacts.

Complications

  • Organ failure (e.g., liver, kidney) from severe exposure.
  • Chronic neurological or dermatological effects.
  • Psychological trauma related to the assault.
  • Long-term disability from irreversible organ damage.

Lifestyle & Prevention

  • Avoidance of arsenic-containing substances in environments where assault risk exists.
  • Prompt medical evaluation after any suspected exposure.
  • Safety measures to reduce access to toxic materials in high-risk settings.

When to Seek Professional Help

Seek immediate medical care if exposure to arsenic is suspected due to assault, especially with symptoms like severe gastrointestinal distress, neurological changes, or skin reactions. Document the assault context clearly for clinical and legal purposes.

Tips for Medical Coders

Use T57.0X3A for initial encounters of arsenic toxicity due to assault. Ensure documentation specifies the assault context and initial encounter status. Code assignment requires clear clinical correlation between the toxic effect and the assault incident.

Book a walkthrough

T57.0X3A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.